Innovent Biologics, Inc. (IVBXF)
USD 6.88
(25.23%)
USD 6.88
(25.23%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.06 Billion CNY | -3.68% |
| 2022 | 6.2 Billion CNY | 2.68% |
| 2021 | 6.04 Billion CNY | 72.79% |
| 2020 | 3.49 Billion CNY | 29.53% |
| 2019 | 2.7 Billion CNY | 72.9% |
| 2018 | 1.56 Billion CNY | 142.84% |
| 2017 | 643.26 Million CNY | 55.65% |
| 2016 | 413.26 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 499.25 Million USD | 0.0% |
| 2023 Q1 | 154.75 Million USD | -67.52% |
| 2023 FY | 5.97 Billion CNY | -3.68% |
| 2023 Q4 | 475.79 Million USD | 84.17% |
| 2023 Q3 | 258.33 Million USD | -32.14% |
| 2023 Q2 | 380.68 Million USD | 145.99% |
| 2022 Q2 | 458.46 Million USD | 0.0% |
| 2022 FY | 6.2 Billion CNY | 2.68% |
| 2022 Q4 | 476.49 Million USD | 130.04% |
| 2022 Q3 | 207.13 Million USD | -54.82% |
| 2021 FY | 6.04 Billion CNY | 72.79% |
| 2021 Q4 | 554.05 Million USD | 0.0% |
| 2021 Q2 | 389.41 Million USD | 0.0% |
| 2020 FY | 3.49 Billion CNY | 29.53% |
| 2020 Q4 | 322.85 Million USD | 0.0% |
| 2020 Q2 | 205.21 Million USD | 0.0% |
| 2019 Q4 | 241.77 Million USD | 0.0% |
| 2019 FY | 2.7 Billion CNY | 72.9% |
| 2019 Q2 | 149.86 Million USD | 0.0% |
| 2018 FY | 1.56 Billion CNY | 142.84% |
| 2017 FY | 643.26 Million CNY | 55.65% |
| 2016 FY | 413.26 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 3.65 Million USD | -138771.84% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -377807.86% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -192850.011% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -17054.956% |
| GB Sciences, Inc. | 1.42 Million USD | -356800.519% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -148793.84% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -2303539.619% |
| Skye Bioscience, Inc. | 13.54 Million USD | -37322.294% |
| Zenith Capital Corp. | 8.94 Million USD | -56590.193% |
| Agentix Corp. | 1.37 Million USD | -369484.97% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -100450.57% |
| Biomind Labs Inc. | 994.18 Thousand USD | -509847.273% |
| ContraFect Corporation | 56.88 Million USD | -8811.747% |
| CSL Limited | 3.44 Billion USD | -46.993% |
| CytoDyn Inc. | 18.05 Million USD | -27975.114% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -271831.215% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -1301297.966% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -8726.26% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -1220131.107% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -337459.583% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -548871.208% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -13508.14% |
| SQZ Biotechnologies Company | 85.61 Million USD | -5821.354% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -247363.837% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -5741.798% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -173747.581% |
| Mesoblast Limited | 5.9 Million USD | -85799.763% |
| Marizyme, Inc. | 19.23 Million USD | -26250.563% |
| Genus plc | 147.7 Million USD | -3332.501% |
| Pharming Group N.V. | 225.49 Million USD | -2148.34% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -60696.307% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -342743.425% |
| IMV Inc. | 37.7 Million USD | -13344.47% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -181590.156% |
| MultiCell Technologies, Inc. | 567.42 USD | -893483386.659% |
| ONE Bio Corp. | 6.44 Million USD | -78576.117% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -5798.893% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -20413.065% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -288009.756% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -75365.804% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 20279316.0% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -31566.015% |
| Alpha Cognition Inc. | 9.7 Million USD | -52135.858% |
| Enzolytics Inc. | 2.17 Million USD | -232512.421% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | -230.597% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -485513.41% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -210708.446% |
| Genscript Biotech Corporation | 825.34 Million USD | -514.266% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -102988.526% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -1936965.481% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -206382.666% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -2955898.811% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -263827.751% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -57647.68% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -114896.171% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | 3.74 Million USD | -135223.999% |
| Helix BioMedix, Inc. | 1.97 Million USD | -256985.02% |
| EV Biologics, Inc. | 531.96 Thousand USD | -952938.751% |
| Q BioMed Inc. | 3.43 Million USD | -147422.63% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -46553.207% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -5003.992% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 22.97 Million USD | -21966.802% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -276169.294% |
| HST Global, Inc. | 140.9 Thousand USD | -3597878.809% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -379538.034% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -450585.299% |
| Halberd Corporation | 74.84 Thousand USD | -6773909.246% |
| Resverlogix Corp. | 12.71 Million USD | -39782.033% |
| Cell Source, Inc. | 4.32 Million USD | -117111.525% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -320904.714% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 7.31 Million USD | -69251.859% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -29101581.878% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.46 Million USD | -205424.735% |
| Kadimastem Ltd | 2.41 Million USD | -210255.535% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -119515.592% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -2793411.309% |
| LadRx Corporation | 3.81 Million USD | -132903.2% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -548871.208% |
| Affymax, Inc. | 39.38 Million USD | -12772.097% |
| Itoco Inc. | 919.14 Thousand USD | -551479.46% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -452965.594% |
| Mobile Lads Corp. | 554.54 Thousand USD | -914126.052% |
| International Stem Cell Corporation | 5.27 Million USD | -96082.963% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 3.82 Million USD | -132612.275% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -20142948.989% |
| Qrons Inc. | 643.67 Thousand USD | -787531.685% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -356980.755% |
| SYBLEU INC | 160.87 Thousand USD | -3151273.729% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -227257.807% |
| Rebus Holdings, Inc. | 664 Thousand USD | -763424.699% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -279025.044% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -9630620.717% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -24921514.315% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -13879.496% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -313237.701% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -688886.526% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -162863.806% |
| Neutra Corp. | 243.82 Thousand USD | -2079213.923% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -28941.668% |
| PureTech Health plc | 144.59 Million USD | -3406.161% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -24642.956% |
| IXICO plc | 4.7 Million USD | -107607.754% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -57531.056% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -4205.639% |
| CSL Limited | 3.89 Billion USD | -30.229% |
| Cellectis S.A. | 97.32 Million USD | -5109.416% |